3 result(s) for Abraxane
|PI Name||Protocol #||Title|
|Charles Lopez||IRB00010540||A Phase III, Multicenter, Open-Label, Randomized Study of nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects with Surgically Resected Pancreatic Adenocarcinoma|
|Eric Anderson||IRB00010866||Safety and Efficacy of nab®-paclitaxel (Abraxane®) in Combination with Carboplatin as First Line Treatment in Elderly Subjects with Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Open-Label, Multicenter Study|
|Khaled Tolba||IRB00011740||TIGER-3: A Phase 3, Open-label, Multicenter, Randomized Study of Oral Rociletinib (CO 1686) Monotherapy Versus Single-agent Cytotoxic Chemotherapy in Patients with Mutant EGFR Non-small Cell Lung Cancer (NSCLC) after Failure of at Least 1 Previous EGFR-directed Tyrosine Kinase Inhibitor (TKI) and Platinum-doublet Chemotherapy|
You may also qualify for Phase 1 Program trials.
For more information: